|Description||AC 261066 is a potent RARβ2 agonist (pEC50 = 8.1).|
|Brife Description||RARβ2 agonist|
|Purity||≥98% by HPLC|
|Synonyms||AC261066; AC 261066; AC-261066; 4-[4-(2-Butoxyethoxy-)-5-methyl-2-thiazolyl]-2-fluorobenzoic acid|
Acitretin sodium is a second-generation, systemic retinoid that has been used in the treatment of psoriasis. It can be considered one of the treatments of choic...
TTNPB potently and selectively activates retinoic acid receptors (EC50s = 21, 4, and 2.4 nM for RARα, RARβ, and RARγ, respectively). And it does not act on reti...
BMS 961 is a potent and selective RARγ agonist (EC50 = 30 and 1000 nM at RARγ and RARβ, respectively) displaying no activity at RARα receptors. It was found tha...
AC 55649 is a potent and isoform-selective RARβ2 receptor agonist (pEC50 = 6.9, 5.7 and 5.6 at RARβ2, RARβ1 and RARα, respectively). It causes inhibition of pro...
Tazarotene could propel either early or late portions of the period leading to differentiation and G0 arrest and is interchangeable with an RARalpha-selective l...
AGN 205728 is a potent and selective RARγ antagonist and has no inhibiton on RARα and RARβ.
Acitretin is a second generation retinoid used for psoriasis.
Ch 55 is a highly potent synthetic analog of retinoic acid which is an effective inhibitor of angiogenesis. It has high affinity for RAR-α and RAR-β receptors, ...